CHIESI VENTURES
Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders. The company funds research and development opportunities for therapies of rare diseases and aims to improve the quality of diagnosis, disease management, care and therapy to all patients affected by rare diseases. It also aims to accelerate the expansion of the Chiesi network in the U.S. among universities, venture capital investors, rare disease patient organiz... ations, and entrepreneurial companies developing treatments for rare diseases. On September 2, 2014, Chiesi Ventures and A. M. Pappas & Associates announced a strategic collaboration. Chiesi Ventures was founded on September 2, 2014, and is headquartered in Parma, Italy with presence in the United States. It is owned by Chiesi Group.
CHIESI VENTURES
Industry:
Venture Capital
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business GStatic Google Static Content Google Cloud Sectigo SSL
Similar Organizations
Fort Ross Ventures
Fort Ross Ventures is a venture capital firm that invests in early growth stage startups with the proven product, technology.
HealthCare Ventures
HealthCare Ventures is a life science venture capital firm that invests in early clinical stage companies which transform patient care.
Mobius Venture Capital
Mobius Venture Capital is an early-stage venture capital fund that invests in various sectors, including healthcare and infrastructure.
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-23 | Glycomine | Chiesi Ventures investment in Series B - Glycomine | 35 M USD |
| 2021-03-22 | Aura Biosciences | Chiesi Ventures investment in Venture Round - Aura Biosciences | 80 M USD |
| 2020-12-09 | Reneo Pharmaceuticals | Chiesi Ventures investment in Series B - Reneo Pharmaceuticals | 95 M USD |
| 2020-06-16 | 4D Molecular Therapeutics | Chiesi Ventures investment in Series C - 4D Molecular Therapeutics | 75 M USD |
| 2019-08-07 | Glycomine | Chiesi Ventures investment in Series B - Glycomine | 33 M USD |
| 2018-11-07 | Mirum Pharmaceuticals | Chiesi Ventures investment in Series A - Mirum Pharmaceuticals | 120 M USD |
| 2018-10-17 | CuraSen Therapeutics | Chiesi Ventures investment in Series A - CuraSen Therapeutics | 54.5 M USD |
| 2018-10-01 | VelosBio | Chiesi Ventures investment in Series A - VelosBio | 58 M USD |
| 2018-09-26 | Minoryx Therapeutics | Chiesi Ventures investment in Series B - Minoryx Therapeutics | 21.3 M EUR |
| 2018-09-05 | 4D Molecular Therapeutics | Chiesi Ventures investment in Series B - 4D Molecular Therapeutics | 90 M USD |
More informations about "Chiesi Ventures"
Investments – ChiesiVentures
Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders. Contact info. BOSTON, MA One Boston Place, #4000 . Boston, MA 02109 (US) PARMA, …See details»
Team and Governance – ChiesiVentures
In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital. Before going back to the Chiesi Group, Giacomo was a consultant with Bain & Co, where he led teams in a variety …See details»
Chiesi Ventures - Crunchbase Investor Profile & Investments
Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders. The company funds research and development …See details»
Chiesi Ventures | Chiesi Global corporate development - Chiesi …
VAT IT 01513360345 Company's Capital: Euro 75.000.000 Companies Register Office - Parma N.15739 REA: 159271See details»
Leadership Team | Chiesi Global Rare Diseases
In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital, an established life science venture capital fund, where he currently serves as Managing Partner. He serves as a Board Member on the Board of the Chiesi …See details»
Chiesi Ventures - Investments, Portfolio & Company Exits
Chiesi Ventures 's most notable exits include 4D Molecular Therapeutics, Aura Biosciences, and Mirum Pharmaceuticals. Which industries has this organization had the most exits in? Show . …See details»
Chiesi Ventures Investor Profile: Portfolio & Exits - PitchBook
Founded in 2014, Chiesi Ventures is the corporate venture capital arm of Chiesi Farmaceutici based in Boston, Massachusetts. The firm prefers to invest in seed, start-ups, and early-stage …See details»
Chiesi Ventures - Investor Profile, Portfolio & Team - Tracxn
Chiesi Ventures - Life Sciences sector focused early stage VC firm investing in the US & Europe. Portfolio of 10 companies. 30 investors have invested with Chiesi Ventures. Team has 2 …See details»
Chiesi Ventures | North Carolina Biotech Center
Chiesi Ventures invests in early stage development opportunities in the area of rare and orphan disorders. Company Location. https://www.chiesiventures.com. c/o A. M. Pappas & …See details»
Chiesi Ventures Fund - Pappas Capital
Chiesi Ventures supports the advancement of high-quality research and development opportunities for therapies that can provide hope for patients and their families. Pappas …See details»
Investment Focus - ChiesiVentures
Chiesi Ventures focuses on creating a better world by investing in promising start-ups that provide services and treatments for rare diseases. ... c/o The Chiesi Group. Largo Belloli 11/A. 43122 …See details»
How one pharma “family business” places patients first
Nov 22, 2024 In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital, an established life science venture capital fund, where he currently serves as Managing Partner. …See details»
Disrupters: Giacomo Chiesi | PharmaVoice
Sep 6, 2022 Before founding GRD, Chiesi launched and built Chiesi Ventures, a venture capital fund focused on rare diseases. He also headed the Chiesi Group’s M&A department, …See details»
Which VCs are investing in rare diseases? - VatorNews
Oct 23, 2023 Description: "Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders.Our goal is to complement the strategic interest of the Chiesi Group by …See details»
Chiesi Ventures, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Chiesi Ventures, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Portfolio Companies - ChiesiVentures
Chiesi Ventures invests in innovative biotech companies developing treatments for rare diseases. ... c/o The Chiesi Group. Largo Belloli 11/A. 43122 Parma, Italy. RESEARCH TRIANGLE …See details»
Chiesi signs a deal with StartUp Health: first investment in the ...
Jun 5, 2018 Chiesi has signed a strategic deal with StartUp Health, a global health innovation company focused on achieving Health Moonshots. StartUp Health has the largest digital …See details»
News – ChiesiVentures
Chiesi Ventures News November 18, 2024 October 10, 2024 SAN CARLOS, Calif., October 10, 2024 – Glycomine, Inc., a clinical-stage biotechnology company focused on developing new …See details»
Advanced Therapies - ChiesiVentures
Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders. Contact info. BOSTON, MA One Boston Place, #4000 . Boston, MA 02109 (US) PARMA, …See details»